EnteroBiotix Ltd.

https://www.enterobiotix.com

LinkedIn: https://www.linkedin.com/company/enterobiotix

EnteroBiotix is a biopharmaceutical company developing novel medicinal products that enhance the gut microbiome and target multiple disease indications. Established in 2017, EnteroBiotix is headquartered in Glasgow, Scotland and operates research laboratories and GMP pharmaceutical manufacturing suites in Glasgow and Aberdeen. The company has raised around £18m in equity investment since incorporation, from investors including Thairm Bio, the Scottish Enterprise, and Kineticos Life Sciences. The company also owns a subsidiary operation called Number 2, which ensures the security and quality of supply of microbiota from human donors. *

	Start	0117-01-01 established
	Industry	microbiomics

	Region	Glasgow
	Country	United Kingdom (GB)
	Street	1 West Regent Street
	City	G2 1AP Glasgow, Scotland
		Address record changed: 2021-09-18

Basic data	Employees	n. a.

		* Document for »About Section«: EnteroBiotix Ltd.. (9/7/21). "Press Release: EnteroBiotix Raises over $21m in Series A Financing to Advance its Microbiome Drug Pipeline". Glasgow.

		Record changed: 2024-04-07

Picture Berlin Partner BIO 2024 International Convention San Diego 650x200px

More documents for EnteroBiotix Ltd.

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)